# Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy

> **NCT05295407** · — · RECRUITING · sponsor: **Endeavor Health** · enrollment: 1000 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **GENETIC:** Genetic Assessment

## Key facts

- **NCT ID:** NCT05295407
- **Lead sponsor:** Endeavor Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-13
- **Primary completion:** 2026-12-13
- **Final completion:** 2027-12-13
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05295407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05295407, "Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05295407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*